Mattawan, MI, United States of America

Lisa A Adams


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Lisa A. Adams: Pioneering Preservative-Free Ophthalmic Solutions

Introduction

Lisa A. Adams, an influential inventor based in Mattawan, MI, has made significant contributions to the field of pharmaceuticals, particularly in ophthalmic drug delivery. With her innovative approach, she has created solutions that aim to improve the treatment of eye infections.

Latest Patents

Lisa A. Adams holds a noteworthy patent for a preservative-free ophthalmic oxazolidinone antibiotic drug delivery system. This composition is designed to be administered topically to the eye and includes a combination of an oxazolidinone antimicrobial drug, such as linezolid, at a therapeutically effective concentration, and a pharmaceutically acceptable cyclodextrin compound. This unique formulation is particularly effective for treating and preventing eye infections caused by gram-positive bacteria, representing a significant advancement in ophthalmic care.

Career Highlights

Currently, Lisa is associated with Pharmacia Corporation, where her work continues to influence the pharmaceutical landscape. Her patent reflects her commitment to developing innovative solutions that enhance patient care and treatment efficacy.

Collaborations

Throughout her career, Lisa A. Adams has collaborated with esteemed colleagues such as Satish Kumar Singh and Paramita Bandyopadhyay, leveraging their expertise to advance her research and develop her groundbreaking inventions.

Conclusion

Lisa A. Adams stands out as a trailblazing inventor in the field of ophthalmic pharmaceuticals. Her dedication to developing preservative-free solutions demonstrates her commitment to innovation and the improvement of healthcare outcomes. As the industry evolves, her contributions will undoubtedly continue to pave the way for future advancements in drug delivery systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…